234 related articles for article (PubMed ID: 23303639)
1. Curcumin and liver disease.
Vera-Ramirez L; Pérez-Lopez P; Varela-Lopez A; Ramirez-Tortosa M; Battino M; Quiles JL
Biofactors; 2013; 39(1):88-100. PubMed ID: 23303639
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological actions of curcumin in liver diseases or damage.
Rivera-Espinoza Y; Muriel P
Liver Int; 2009 Nov; 29(10):1457-66. PubMed ID: 19811613
[TBL] [Abstract][Full Text] [Related]
3. Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-alpha.
Ramirez-Tortosa MC; Ramirez-Tortosa CL; Mesa MD; Granados S; Gil A; Quiles JL
Free Radic Biol Med; 2009 Oct; 47(7):924-31. PubMed ID: 19539747
[TBL] [Abstract][Full Text] [Related]
4. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-beta modulation and oxidative stress.
Reyes-Gordillo K; Segovia J; Shibayama M; Tsutsumi V; Vergara P; Moreno MG; Muriel P
Fundam Clin Pharmacol; 2008 Aug; 22(4):417-27. PubMed ID: 18705752
[TBL] [Abstract][Full Text] [Related]
5. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation.
Fu Y; Zheng S; Lin J; Ryerse J; Chen A
Mol Pharmacol; 2008 Feb; 73(2):399-409. PubMed ID: 18006644
[TBL] [Abstract][Full Text] [Related]
6. [Antioxidant therapy in chronic liver diseases].
Lengyel G; Tulassay Z
Orv Hetil; 2006 Jun; 147(24):1113-8. PubMed ID: 16865855
[TBL] [Abstract][Full Text] [Related]
7. Potential Mechanisms Underlying the Role of Coffee in Liver Health.
Alferink LJM; Kiefte-de Jong JC; Darwish Murad S
Semin Liver Dis; 2018 Aug; 38(3):193-214. PubMed ID: 30041273
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
Leclercq IA; Farrell GC; Sempoux C; dela Peña A; Horsmans Y
J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
[TBL] [Abstract][Full Text] [Related]
9. Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes.
Wang ME; Chen YC; Chen IS; Hsieh SC; Chen SS; Chiu CH
J Nutr Biochem; 2012 Oct; 23(10):1352-66. PubMed ID: 22221674
[TBL] [Abstract][Full Text] [Related]
10. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective.
Farzaei MH; Zobeiri M; Parvizi F; El-Senduny FF; Marmouzi I; Coy-Barrera E; Naseri R; Nabavi SM; Rahimi R; Abdollahi M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29966389
[TBL] [Abstract][Full Text] [Related]
11. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
Gambino R; Musso G; Cassader M
Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of curcumin and its synthetic analogue on tissue lipid peroxidation and antioxidant status during nicotine-induced toxicity.
Kalpana C; Sudheer AR; Rajasekharan KN; Menon VP
Singapore Med J; 2007 Feb; 48(2):124-30. PubMed ID: 17304391
[TBL] [Abstract][Full Text] [Related]
13. [Pay attention to insulin resistance in chronic liver diseases].
Ji G
Zhong Xi Yi Jie He Xue Bao; 2010 Jan; 8(1):1-6. PubMed ID: 20082750
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of curcumin and an analog of curcumin on alcohol and PUFA induced oxidative stress.
Rukkumani R; Aruna K; Varma PS; Rajasekaran KN; Menon VP
J Pharm Pharm Sci; 2004 Aug; 7(2):274-83. PubMed ID: 15367386
[TBL] [Abstract][Full Text] [Related]
15. [Molecular and cellular mechanisms of curcumin action--beneficial effect on organism].
Sikora-Polaczek M; Bielak-Zmijewska A; Sikora E
Postepy Biochem; 2011; 57(1):74-84. PubMed ID: 21735822
[TBL] [Abstract][Full Text] [Related]
16. Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury.
Han CW; Kang ES; Ham SA; Woo HJ; Lee JH; Seo HG
Pharm Biol; 2012 Oct; 50(10):1281-8. PubMed ID: 22857151
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits HMGB1 releasing and attenuates concanavalin A-induced hepatitis in mice.
Wang C; Nie H; Li K; Zhang YX; Yang F; Li CB; Wang CF; Gong Q
Eur J Pharmacol; 2012 Dec; 697(1-3):152-7. PubMed ID: 23063543
[TBL] [Abstract][Full Text] [Related]
18. Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-α-induced oxidative stress, colitis and hepatotoxicity in mice.
Mouzaoui S; Rahim I; Djerdjouri B
Int Immunopharmacol; 2012 Jan; 12(1):302-11. PubMed ID: 22036766
[TBL] [Abstract][Full Text] [Related]
19. The keratin cytoskeleton in liver diseases.
Zatloukal K; Stumptner C; Fuchsbichler A; Fickert P; Lackner C; Trauner M; Denk H
J Pathol; 2004 Nov; 204(4):367-76. PubMed ID: 15495250
[TBL] [Abstract][Full Text] [Related]
20. [Studies on vitamin B12 resorption in chronic liver diseases].
Konrad H; Teichmann W; Kiencke H; Bielka B; Claus R
Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):179-83. PubMed ID: 4792418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
